American Century Companies Inc Ionis Pharmaceuticals Inc Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, American Century Companies Inc holds 6,293 shares of IONS stock, worth $210,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,293

Previous 13,441 53.18%

Holding current value

$210,563

Previous $640,000 60.62%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$40.06 - $51.86 $286,348 - $370,695	-7,148 Reduced 53.18%	6,293 $252,000
Q2 2024 Aug 07, 2024	BUY	$36.45 - $47.7 $2,296 - $3,005	63 Added 0.47%	13,441 $640,000
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $6,808 - $8,675	162 Added 1.23%	13,378 $579,000
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $573,442 - $682,342	13,216 New	13,216 $668,000
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $14,437 - $17,673	375 Added 2.97%	12,982 $588,000
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $19,309 - $24,091	-556 Reduced 4.22%	12,607 $517,000
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $594,668 - $729,610	-17,709 Reduced 57.36%	13,163 $470,000
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $771,836 - $967,290	20,793 Added 206.3%	30,872 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $99,534 - $132,549	2,724 Added 37.04%	10,079 $446,000
Q2 2022 Aug 12, 2022	BUY	$31.71 - $43.0 $55,841 - $75,723	1,761 Added 31.48%	7,355 $272,000
Q1 2022 May 11, 2022	BUY	$29.88 - $37.04 $167,148 - $207,201	5,594 New	5,594 $207,000
Q4 2021 Feb 07, 2022	SELL	$25.61 - $35.1 $5.11 Million - $7 Million	-199,346 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$33.54 - $40.55 $900,012 - $1.09 Million	-26,834 Reduced 11.86%	199,346 $6.69 Million
Q2 2021 Aug 05, 2021	SELL	$34.54 - $47.25 $24.7 Million - $33.9 Million	-716,498 Reduced 76.01%	226,180 $9.02 Million
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $12.8 Million - $19.3 Million	-301,852 Reduced 24.25%	942,678 $42.4 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $4.13 Million - $5.5 Million	-91,184 Reduced 6.83%	1,244,530 $70.4 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $5.32 Million - $7.06 Million	-112,168 Reduced 7.75%	1,335,714 $63.4 Million
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $1.89 Million - $2.46 Million	40,254 Added 2.86%	1,447,882 $85.4 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $360,131 - $548,853	-8,657 Reduced 0.61%	1,407,628 $66.6 Million
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $2.39 Million - $2.9 Million	44,471 Added 3.24%	1,416,285 $85.6 Million
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $138,082 - $168,686	2,338 Added 0.17%	1,371,814 $82.2 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $4.29 Million - $5.95 Million	69,096 Added 5.31%	1,369,476 $88 Million
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $16.1 Million - $24.7 Million	-304,594 Reduced 18.98%	1,300,380 $0
Q4 2018 Feb 13, 2019	BUY	$43.37 - $59.54 $18 Million - $24.7 Million	414,255 Added 34.79%	1,604,974 $86.8 Million
Q3 2018 Nov 02, 2018	BUY	$42.88 - $53.7 $237,426 - $297,336	5,537 Added 0.47%	1,190,719 $61.4 Million
Q2 2018 Aug 08, 2018	BUY	$40.53 - $50.7 $253,960 - $317,686	6,266 Added 0.53%	1,185,182 $49.4 Million
Q1 2018 May 03, 2018	SELL	$44.08 - $55.05 $96,667 - $120,724	-2,193 Reduced 0.19%	1,178,916 $52 Million
Q4 2017 Feb 02, 2018	BUY	$50.3 - $64.39 $1.84 Million - $2.36 Million	36,583 Added 3.2%	1,181,109 $59.4 Million
Q3 2017 Nov 01, 2017	BUY	$45.56 - $59.57 $52.1 Million - $68.2 Million	1,144,526	1,144,526 $58 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.75B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Ionis Pharmaceuticals Inc Transaction History